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Background: Health technology assessment (HTA) is mostly used in the context of high- and middle-income
countries. Many “resource-poor” settings, which have the greatest need for critical assessment of health technology,
have a limited basis for making evidence-based choices. This can lead to inappropriate use of technologies, a problem
that could be addressed by HTA that enables the efficient use of resources, which is especially crucial in such settings.
There is a lack of clarity about which HTA tools should be used in these settings. This research aims to provide an
overview of proposed HTA tools for “resource-poor” settings with a specific focus on sub-Saharan Africa (SSA).
Methodology: A systematic review was conducted using basic steps from the PRISMA guidelines. Studies that
described HTA tools applicable for “resource-limited” settings were identified and critically appraised. Only papers
published between 2003 and 2013 were included. The identified tools were assessed according to a checklist with
methodological criteria.
Results: Six appropriate tools that are applicable in the SSA setting and cover methodological robustness and ease
of use were included in the review. Several tools fulfil these criteria, such as the KNOW ESSENTIALS tool, Mini-HTA tool,
and Multi-Criteria Decision Analysis but their application in the SSA context remains limited. The WHO CHOICE method
is a standardized decision making tool for choosing interventions but is limited to their cost-effectiveness. Most
evaluation of health technology in SSA focuses on priority setting. There is a lack of HTA tools that can be
used for the systematic assessment of technology in the SSA context.
Conclusions: An appropriate HTA tool for “resource-constrained” settings, and especially SSA, should address
all important criteria of decision making. By combining the two most promising tools, KNOW ESSENTIALS and
Multi-Criteria Decision Analysis, appropriate analysis of evidence with a robust and flexible methodology could
be applied for the SSA setting.
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Health technology assessment (HTA) is a multidisciplin-
ary field of policy analysis that examines the medical,
economic, social, and ethical implications of the incre-
mental value, diffusion, and use of a medical technology
in health care [1]. Currently, HTA is mostly used in the
context of developed countries. Several methodologies
exist for “resource-poor” settings but implementation of
HTA and transparent use in most African countries is
still limited [2]. In addition, some methodological as-
pects of HTA do not fit into the setting of developing
countries and need to be adapted appropriately according
to specific needs [2]. Especially in “resource-constrained”
settings, the need for the systematic evaluation of health
technology and of the available alternative technologies
has never been greater [3,4]. HTA is performed in order
to improve the quality of health care and ensure good
value for money investments in any setting. It is because
of this that HTA should form the basis for health technol-
ogy policies especially in “resource-poor” settings with
limited health sector budgets.
The current lack of HTA in sub-Sahara Africa (SSA)
can be attributed to the lack of capacity to undertake
HTA. Even though countries like South Africa currently
employ HTA to a small degree and have begun the
process of forming a HTA mechanism, the lack of
capacity coupled with a weak health system capacity
to implement interventions are contributing to wide-
spread implementation of HTA. Another problematic
issue is the limitation of high-quality data availability
and lack of research evidence, especially in the con-
text of “resource-limited” health systems like the assess-
ment of health states [5,6]. This reduces the ability for
“resource-poor” settings to implement rigorous HTA
practices. In addition, “resource-limited” countries have
few resources to support HTA, which then undermines
the ability of HTA to utilize appropriate incentives (that
would promote more efficient management of resources.
Incentives for HTA in resource-limited settings:
What are the incentives for resource-limited coun-
tries to develop HTA agencies?
1 – Providing international guidelines and model
essential medicines lists as well guidance on good
and ethical governance practices specifically in li-
aison with ethic review committee and bioethics
committee
Low-income countries with very limited capacity and
countries that face major challenges of lack of transparency
in decision-making are likely to face difficulty implement-
ing HTA for medicines effectively. Use of international
guidelines and model essential medicines lists can help
such countries to incorporate HTA in their policies.2 – Complement HTA with evidence-based guidelines
Policies to encourage doctors to prescribe formulary
medicines and follow evidence-based guidelines are needed
to complement HTA.
3 – Strengthening capacity in HTA before to set-up
HTA agencies through national capacity building
workshops specifically for decision makers and
health professionals
Capacity for HTA in resource limited settings should
be established early and supported; prerequisites and
barriers are extensive but not insurmountable and must
be considered as HTA processes are developed.
Decisions in many “resource-poor” settings can easily
be influenced by past experience without an evidence
base and by preferences of donor agencies and lobbying
pressure for new technologies, for example from commer-
cial organisations or global funding and donor organiza-
tions [2]. This can lead to the use of technologies which
do not address health needs and in effect contribute to the
inefficient use of resources [7]. Decisions made in this
context often do not reflect local values and evidence
based local information on clinical and cost effectiveness
[2]. As a result of this, many resources are disproportion-
ately allocated or wasted. The need for HTA becomes
more prominent when the need for collective decision
making for the good of the whole is necessary. It also
becomes apparent that HTA in “resource-poor” settings
cannot be addressed the same as it is in high-income
countries [8]. Equity and equality considerations are differ-
ent from these in developed countries. These include
more important social issues like poverty reduction [9].
There is a clear need for HTA use in “resource-limited”
settings, and SSA countries in particular, as it is these
countries especially that cannot afford to waste resources.
Not only would HTA highlight health technologies that
would be too costly relative to their benefits, but would
also identify potentially harmful and ineffective technolo-
gies. In light of a higher percentage of insured patients
stemming from advanced economic development and the
potential to purchase more and more complex, and ex-
pensive, health technologies, the introduction of HTA into
public health policies becomes more evident. The WHO
resolution on “Health Intervention and Technology
Assessment in Support of Universal Health Coverage”
passed on 24 May 2014 by the World Health Assembly
provides an important mandate for SSA countries to ac-
celerate their HTA efforts.
Objectives
The research objectives of this systematic review are to
provide an overview of HTA tools used in “resource-
constrained” settings, with a specific focus on the
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because it is the region with the least covered area by
HTA practices and also the most “resource-constrained”
setting. Another objective is to determine how many of
the appropriate HTA tools identified in this review were
applied for the assessment of medical devices.
Methods
Search method
The PRISMA guidelines for conducting systematic re-
views were followed [10]. Within the study the following
databases were searched: PubMed, Science Direct, Scopus,
Ebscoh, and EconLit alongside the journals Health Policy
and Planning, Cost-Effectiveness and Resource Allocation,
and the WHO Bulletin (see Appendix for detailed search
string). To ensure optimal coverage, additional articles
were found within the reference section of retrieved arti-
cles and through citation snowballing by undertaking
wider searches by author name for those appearing as key
publishers in the area. Additionally, the web pages of the
WHO and the World Bank were searched manually. The
search was limited to articles published within the 2003
and 2013 timeframe and excluded non-empirical studies
or those that did not focus on a HTA tool.
Selection of manuscripts and data extraction
Articles that met the inclusion criteria of an evidence-
based HTA tool appropriate for the use in the SSA
context were retrieved and examined more closely. The
quality of research papers was evaluated according to
adequate description of the theoretical framework, back-
ground, and methodology [11].
For those papers that fulfilled the criteria for quality,
data was extracted according to the following content:
date published, study funding source, possible conflicts
of interest, study objectives, target population, applica-
tion of tool, site/setting, study focus, HTA tool proposed
or approach used in the paper, description of tool or ap-
proach, stand alone or support tool, aspects of clinical ef-
fectiveness, costs and contextual issues addressed by tool
or approach, all stakeholders involved, literature search in-
corporated, results of implementation, and focus on med-
ical technology/intervention.
Each study was described by addressing the criteria in
the data extraction form (Table 1).
The HTA tool or approach found in each study were
critically appraised using a second data extraction form
(Table 2) based on proposed criteria for the assessment
of HTA activities [12]. These criteria are formed by a series
of 15 principles, as described by Drummond et al. [12],
which cover the structure of HTA programs, methods of
HTA, processes for conduct of HTA, and use of HTAs in
decision making. This set of principles was utilized to en-
sure robustness of the included HTA approaches andtools. The extraction form prompted i) the context and
applicability of the described tool (geographical focus, tar-
get setting, reasons for use, degree of needed training, and
experts); ii) measures for sensitivity and effectiveness (clin-
ical effectiveness, cost effectiveness, context sensitivity);
iii) the approach to HTA assessment (type of tool, inclu-
sion of full social perspective, use of available evidence,
transparency, generalizability, result focus, ling to decision
making), and iv) if the described tool was piloted for med-
ical devices.
Criteria addressing areas particular to SSA were in-
cluded in the evaluation to assess how adaptable the tool
or approach would be for that setting. The criteria in-
cluded the following: ease of training, flexibility of evidence
requirement, economical standing, and local context con-
sideration (Table 3). These criteria have been elaborated in
consensus with our Research Consortium Members in-
cluding representatives from SSA countries.
Results
The search retrieved 1,073 papers in total, of which six ful-
filled the inclusion criteria (PRISMA flowchart, Figure 1).
Data was extracted from the six papers published between
2003 and 2013.
HTA tools overview:
 WHO CHOICE cost-effectiveness analysis tool [13]
 KNOW ESSENTIALS tool using thirteen criteria
related to context-specific HTA and prioritization of
these criteria [8]
 Weighting of Multi-Criteria Decision Analysis criteria
on the basis of corresponding HTA report [14]
 Adaptation of Mini-HTA or hospital-based HTA
tool for the decision-making related to medical de-
vices purchased in a hospital setting [15]
 Equity-oriented toolkit for HTA, containing four
elements: burden of illness, community effectiveness,
economic evaluation and knowledge translation [16]
 Mapping system using Analytic Hierarch Process
(AHP) methods between different diseases and their
matching technologies to minimize technology
underutilization [17]
None of the papers were funded or stated funding by
other sources. Four studies proposed novel tools for
HTA [8,15-17] and the other two used current HTA ap-
proaches originally developed for high-income settings
[13,14]. One study specified their target population to be
in SSA countries [15], the others focused on “resource-
poor” settings [13,14,16,17] and settings without formal
HTA [8]. However, all studies included in the review can
be applied in the SSA setting. From the proposed tools,
two were stand-alone [8,16] and the other two were sup-
port tools [15,17]. The support tools served as decision
Table 1 Extraction form for study characteristics
Author(s) Mathew Abaza and Tawfik Hutubessy et al. Miot et al. Govender et al. Ueffing et al.
Study name KNOW ESSENTIALS:
A tool for informed
decisions in the absence



































Published date 2011 2008 2003 2012 2011 2009
Study funding source(s) None Not stated Not stated Not stated Not stated Not stated
Possible conflicts
of interest




















of medical devices to be
purchased when certain
diseases are to be dealt
with and allow non-technical
personnel to make correct
and appropriate acquisitions
Outline the process
by which country level
decision makers and
programme managers
can carry out their own
context-specific analysis
of the relative cost-effectiveness
of interventions for reducing





Field testing of the
EVIDEM framework
for decision-making
on a screening test
by a private health
plan in South Africa














to scale up training
and education of
health workers
Target population Settings lacking formal
HTA systems





Yes, pilot tested Yes, pilot tested No Yes Yes No
Site/setting Africa (hypothetical) Not stated n/a South Africa South Africa n/a









































Table 1 Extraction form for study characteristics (Continued)
Expressed need for
tool or approach
Lack of formal HTA or






Lack of HTA and the
recognition for the need
of HTA in developing
countries
Shortage of technical expertise
and health service capacity to
utilize CEA information
Need for transparency

















part of health care
resources
HTA tool proposed and
designed to be applied
for specific medical technologies
KNOW ESSENTIALS Decision support
database software





HTA approach used in the paper
(if new tool not proposed)
n/a n/a Use of CEA information
from the WHO-CHOICE
project, generalized CEA







Applied in the context of
medical devices?
No Yes No Yes Yes No




(KN, O, W), essential
criteria (E, S, S, E),
and other criteria
















is insufficient to classify
green or red. For last
six elements, not
applicable (white)








three main forms. First
form enables user to




Second form lists relevant
equipment according to
selected criteria. Equipment
is ordered by a priority
scheme depending on
total number of diagnostic







these features. The third






as well as opportunities
presented by new interventions
and presents it in a way that
can be translated across
settings by i) evaluating the
costs and health benefits of a
set of related interventions,
singly and in combination, with
the “null scenario”; ii) using CEA
results to classify interventions
into those that are very
cost-effective, cost-ineffective,
and somewhere in between
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of the MCDA matrix
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Table 1 Extraction form for study characteristics (Continued)
technology is rejected,
if not it proceeds to
Essential Criteria. If
any coded red, health
technology is rejected,











related criteria on the
appraisal. Adoptability




Stand-alone tool or a support
tool for existing decision
making process?
Stand alone Support Support Stand alone Support Stand alone
Results of implementation Atemisinin-based treatment
for severe or complicated
malaria in children should
be incorporated as the
first-line treatment in the
National guideline.
(hypothetical)
Concluded that this tool
would save effort from
technical personnel and is
friendly enough to be used
by non-technical personnel.
It would also be a helpful
tool for the determination of
budget and other non-
diagnostic criteria.
n/a Resulted in a
consideration by the
health plan to only


















of the evidence on
the intervention, and
consideration of all
key elements of the
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technology or on the























Table 2 Extraction form for principles of HTA activities according to Drummond et al. [12]
Author(s) Mathew Abaza and Tawfik Hutubessy et al. Miot et al. Govender et al. Ueffing et al.
Study name KNOW ESSENTIALS: A tool for
informed decisions in the







priority-setting in the health
sector
Field testing of a multicriteria
decision analysis (MCDA)
framework for coverage of a




hospitals: the mini-HTA tool
Equity-oriented toolkit for health
technology assessment and
knowledge translation: application
to scaling up of training and
education for health workers
Structure of HTA Programs
Are the goal and
scope of the HTA
explicit and
relevant to its use?
Yes, outcomes of interest are
clearly defined at the
beginning of process (no
detailed scoping document
mentioned)
Yes, deals with specific
disease and all relevant
health technologies
(medical devices)
Yes, cost effectiveness analysis
of specific health technology
Yes, HTA report clearly outlines
the purpose
Yes, the form clearly asks to
define medical technology
and scope of proposal
Yes, criteria and requirements
are clearly defined
Is it unbiased and
transparent?
Yes, evidence based and steps






Yes, evidence based and
systematic approach
Yes, evidence based and
priorities of stakeholders are
clearly defined and addressed
No, the stakeholders
working on the form can
make subjective
assessments
Yes, evidence based and
different stakeholders are
involved
Does it include all
relevant
technologies?
Yes, takes into account
alternatives






Yes, the WHO-CHOICE project
used includes an extensive
database of evidence
Yes, considers alternatives Yes, considers
alternatives
Not stated
Does a clear system
for setting priorities
exist?
Not stated, does not mention
priority setting prior to the
implementation of tool
Yes, systematic search by
software of medical
devices most relevant to
stakeholder’s preferences
Not stated, does not mention
priority setting prior to the
implementation of approach
Yes, weights were assigned to
criteria of the framework by
stakeholders





Yes, includes concepts of








Yes, assesses available evidence
to determine costs of technology
and providing the technology
and its cost-effectiveness. Also
assesses effectiveness and safety
of technology




Yes, tool determines cost-
effectiveness and assesses the
benefits and drawbacks of
implementing or not implementing
the health technology along with
combinations of health technologies
Yes, HTA report assesses the
economics and various benefits
of the intervention
Yes, addresses costs for
different stakeholders
and assesses the risks
and benefits of the
health technology
Yes, in its economic evaluation it
assesses the benefits and costs
as well as the trade-offs be-
tween equity and efficiency





evidence and long-term out-
comes of using or rejecting the
health technology




Yes, with the use of the
WHO-CHOICE project
databases for evidence and
one of its tools, PopMod, for




Yes, a thorough search for
evidence in different databases
and other sources is undertaken
for each criterion
Yes, a search and quality
assessment is undertaken
of the available literature
Yes, uses a strong evidence
base
Is a full societal
perspective
considered?
Yes, takes into account social
issues and interests of different
stakeholders
Not stated Not stated Not stated Yes, takes into
consideration effects of
proposal on other
departments in the hospital
and the cooperation with
other hospitals




























Not stated Not stated Yes, with the use Monte Carlo
League software, an analytical
tool, to find the uncertainty
around point estimates
Yes, quality of evidence is
assessed in the HTA report
portion of approach
Yes, the person filling out









transferability of evidence from
similar cohorts needs to be
justified
Not stated Yes, the WHO-CHOICE project
uses international dollars to be
able to make meaningful com-
parisons and adjustments ac-
cording to practice settings are
made to resulting estimates of
generalized CEA
Yes, local costs were used when
assessing cost-effectiveness to im-
prove transferability
Not stated Yes, considers community
effectiveness or the “real world”
efficacy of an intervention




Yes, tool includes or considers
stakeholders throughout its
process






No, not all stakeholders
addressed
Yes, key stakeholders are
included throughout the process
Yes, key stakeholders are
included or considered
throughout the process
Yes, forms a national planning
authority that brings together
different stakeholders
Is all available data
actively being
sought?
Yes, all available data is sought
and used in decision making
table





Yes, all available data is sought
including contextual data
Yes, all available data is sought
during the HTA report process
Yes, all available data is
sought and consulting a
librarian to ensure quality
is advised
Yes, strong evidence base is




Not stated Not stated Not stated Not stated Not stated Not stated
Use of HTA in Decision-Making
Is it timely? Not stated Yes, it is a system of
three forms that can be
done very quickly
Not stated Not stated Yes, the form takes










Yes, the Decision-Making Table
allows decision makers to see
the evidence related to the
criteria and become informed of
the health technologies
being assessed
Not stated Not stated Yes, the HTA report allows
decision makers to see the
evidence related to the criteria
and become informed of the
health technologies being
assessed
Yes, the form gives a
clear overview for
decision makers
Yes, it has included new
advances in knowledge
translation






Yes, HTA findings and decision
making process are clearly
separate
Not stated Not stated Yes, HTA findings and decision
making process are clearly
separate
Yes, the purpose of the
mini-HTA is stated to be
only part of the basis of























Table 3 Extraction form for principles for HTA activities in SSA
Author(s) Mathew Abaza and Tawfik Hutubessy et al. Miot et al. Govender et al. Ueffing et al.
Study name KNOW ESSENTIALS: A tool for
informed decisions in the











setting in the health sector




of a screening test for
cervical cancer in South
Africa
Purchasing of medical






scaling up of training and
education for health workers
Ease of training Yes, it is an easy to use tool
with clear guidelines and
criteria
Yes, it is an easy to






Yes, not a difficult
approach
Yes, the mini-HTA tool is easy to
use and the questions on the
form are clear





Yes, it allows the use of less
systematic evidence
gathering with justification
Yes, all evidence in
the form of data
about medical
devices is provided
Yes, data to assess the
effectiveness of a medical
technology not only come
from reviews of evidence,
but population surveys and
expert opinion
Yes, available data in
local context is used to
customize framework
Yes, available data in the local
context is used
No, only mentions sources
such as The Cochrane Library




Yes, does not require
expensive equipment or
services
Yes, user would only
need a computer and
the software
Yes, does not require
expensive equipment or
services
Yes, does not require
expensive equipment or
services
Yes, tool only comprises of one
form and not expensive
equipment or services are
required








Yes, it considers the local
context throughout its
process
No, the tool itself
does not consider the
local context
Yes, modifications
according to local context
is recommended by
approach
Yes, HTA report is
tailored to reflect local
context
Yes, it is flexible and adapted to
fit the local context
Yes, involves stakeholders in
the process which bring in a
contextual perspective
Considerations Does not include an explicit
priority setting system.
However, this tool is used to
assess specific health
technologies so it is further
down in the HTA process.
Evidence has the potential of
not being very robust
Economical standing
of this tool is
dependent on the
price of the decision
making assistance
software
Economical standing of this
approach is dependent of
amount of special training
needed
The mini-HTA tool is a fast tool;
however, it is not very
comprehensive and only vaguely
addresses the principles that it
proposes. In addition, one of its
limitations is that it is only applied






















Records identified through 
database searching
(n =1005)
Pubmed: n = 810
Scopus: n = 4
Science Direct: n = 78
EbscoH: n = 87

























Additional records identified 
through other sources
(n = 68 )
WHO Bulletin: n = 63
Health Policy and Plan ning: n = 2
World Bank: n = 1
WHO: n = 2
Records after duplicates removed





high-income country: n = 54
not HTA-tool-related: n = 128
background on HTA: n = 155
Full-text articles assessed 
for eligibility
(n =  57 )
Full-text articles excluded, with 
reasons
(n =  51)
only economic analysis: n = 7
priority setting focus: n = 29
tool not described sufficiently: n = 3
no sufficient HTA information: n = 12
Studies included in 
qualitative synthesis
(n =6 )
Figure 1 PRISMA flow diagram.
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lar disorder equipment [17] and the scaling up of train-
ing and education of health workers [16]. The current
HTA approaches used in the studies were: multi-criteria
decision analysis (MCDA) [14], the WHO-CHOICE pro-
ject [13], and generalized cost-effectiveness analysis [13].
Four papers applied their tool or approach [8,14,15,17],
two of those were pilot tests [8,17]. The other two ap-
proaches and tools were not applied and only described
proposed HTA approaches or tools [13,16].
Two of the tools were focused on pharmaceuticals [8,13],
whereas three HTA tools were focused on medical devices
[14,15,17]. For the medical devices, varying contexts were
chosen: one study focused on the introduction of a screen-
ing test [14], another on the underutilisation of medical de-
vices [17] and a third study focused on the decision-making
process for the purchasing of medical devices [15]. One
tool was centred on a health education intervention [16].
Structure of HTA programs
All of the papers were found to explicitly address relevant
goals and scopes of their HTA tool or approach. Five studies
were unbiased and had transparent processes [8,13,14,16,17].
One tool required subjective assessment during its process
[15]. Five methods included all relevant technologies by
considering all alternatives [8,14,15,17] or by using anextensive database to do so [13], while the sixth study did
not state if this was addressed [16].
Methods of HTA
A wide range of evidence and outcomes was considered
by all studies [8,13-17] and appropriate methods for asses-
sing costs and benefits were taken up by five approaches
[8,13-16]. One study did not currently assess the costs
[17]. Three considered a full societal perspective [8,15,16],
whereas the other three failed to state this [13,14,17]. Only
three of the tools or approaches stated explicitly character-
izing uncertainty surrounding their estimates [13-15]. Is-
sues of generalizability and transferability are addressed by
four of the papers [8,13,14,16].
Processes for conducting HTA
All of the approaches required for all available data to be
sought [8,13-17]. Two of the papers failed to actively in-
clude all key stakeholders [13,17], whereas all others in-
cluded key stakeholders by including them in the process
or considering them throughout [8,14-16]. How findings
would be monitored was not stated in any of the papers.
Use of HTA in decision-making
Only two studies mentioned a timeframe for completing
the HTA, which also was timely [15,17]. Findings were
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by four tools or approaches [8,14-16]. Three of the pa-
pers clearly defined the link between HTA findings and
decision-making processes [8,14,15], while the others did
not state this [13,15,17].
Principles for HTA activities specific for SSA
In the context of SSA, five papers presented tools or ap-
proaches that were easy to use [8,14-17], whereas one
required special training to carry out the generalized
cost-effectiveness analysis [13]. The evidence require-
ment was flexible and included available data whether
from a literature search or other less rigorous, yet justified,
sources when it was not available for five of the studies
[8,13-15,17]. One was not as flexible by requiring the data
to be collected in databases such as the Cochrane Library
and no additional alternate sources were mentioned [16].
Only one of the papers failed to address the local context
explicitly in their tool [17].
Discussion
HTA advantages and areas of use
The advantages of using HTA are first and foremost the
systematic evaluation of cost and effectiveness of med-
ical technologies and allowing health systems to achieve
the greatest good for the greatest number of patients.
Chalkidou et al. highlight the importance of HTA for uni-
versal health coverage systems by efficiently and equitably
allocating resources [18]. This focused resource use has an
effect on better budgeting and long-term financial sustain-
ability of the health systems in SSA countries. It is crucial
that the increased use of HTA in these countries is com-
plemented by capacity building and increased expertise in
the HTA area in order to ensure a sustainable infrastruc-
ture [19]. International collaboration among HTA bodies
can facilitate the development of methods and more effi-
cient assessment processes, and facilitate knowledge trans-
fer and capacity-building in less established HTA systems
and programmes.
Another area of need is emerging for relevant applications
of HTA, namely its use in global funding organisations as a
means for increased value for money. Teerawattananon
et al. have argued for the use of HTA approaches for
the Global Fund to Fight HIV/AIDS, Tuberculosis and
Malaria in order to provide strategic directions for the
prioritization of health care interventions currently funded
by the organization [20]. Other global health initiatives
and national donor countries may follow suit in conduct-
ing HTAs before, during, and after grant implementa-
tion in order to improve efficiency and identify areas of
unmet need (in June 2014 the Gates Reference Case
has been launched which involves more principled cost-
effectiveness analysis in health programme funding by
the Bill and Melinda Gates Foundation). Therefore, thenecessity for the thorough evaluation and fine-tuning
of relevant HTA tools and approaches becomes more
evident.
Lack of application
The review shows widespread methodological heterogen-
eity among the different studies included in the review.
The HTA tools or approaches used varied a lot in their
context and scope. There was a lack of application of some
tools for a specific medical technology or intervention in
the SSA setting. The tools analysed in this review would
benefit from a wider application and pilot-testing as well as
user friendliness. A direct comparison between applying
the tools or approaches would also highlight the advan-
tages and disadvantages of each tool or approach and guide
decision makers in regards to which tools should be used,
in which context, and for which tasks.
Robustness of HTA
While the need for HTA in SSA is evident, the robustness
of HTA cannot be neglected when resources are limited.
The majority of the approaches involved a well-rounded
structure for their HTA that was accomplished with explicit
goals and scopes, unbiased and transparent processes, and
the inclusion of alternative technologies and some also had
priority setting processes incorporated [14,16,17]. In this
context, “priority-setting” focuses on identifying different
health technologies for which an evaluation regarding their
inclusion in the health system is warranted, while HTA re-
lates to the actual evaluation of a specific technology.
The methods utilized in the approaches followed the
principles for HTA activities in most of the studies. How-
ever, one approach that seemed to be limited by its pur-
pose as a computerized decision-making aide [17] seemed
to lack robustness in its methods by not assessing costs.
The processes for conducting HTA were limited for some
approaches by the exclusion of key stakeholders [13,17], an
integral dimension of good practice in HTA methodology.
In addition, the monitoring of HTA practices lacked in all
of the studies. When assessing the use of HTA in decision-
making, two approaches showed limitations [13,17]. One
approach completely lacked the inclusion of the principles
in this section, but this may be connected with the priority
setting orientation of the approach [13]. All of the tools
addressed the issue of economic resource deficiency; how-
ever, they lacked specifications explicitly considering the
local context [17], requiring little training for their use
[13] and being flexible with the data necessary for under-
taking the HTA when there is limited data or access avail-
able [16].
Potential opportunities
In general, the review revealed that the majority of ap-
proaches were not applied in a stand-alone manner and
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making processes. The analysis revealed that two
approaches show particular promise for further investiga-
tion: the KNOW ESSENTIAL tool for its compact, yet
comprehensive coverage [8], and the MCDA approach for
the active involvement of stakeholders in its process [14].
These incorporated all aspects important for the SSA con-
text into their evaluation such as contextual issues, flexible
data collection practices, and economical and easy use.
However, it is important to point out that the MCDA ap-
proach is, per se, focused on assessing available evidence
and not generating new evidence as in the case with other
HTA tools. Although several MCDA tools have been ap-
plied in the SSA setting, we only included one study in
our review as it was explicitly connected with the asses-
sing of evidence in the context of a HTA report.
Even though the mini-HTA tool [15] also incorporated
the majority of the principles for HTA activities and all
of the contextual SSA principles, it had a number of lim-
itations related to comprehensive and detailed coverage
due to its restriction to the hospital setting [15]. The
critical appraisal also revealed that other tools did not meet
all of the contextual criteria for SSA [13,16,17] or were
limited to a position further down-stream in the decision
making process. Although it is possible to weight the cri-
teria applied in the KNOW ESSENTIALS tool, it would be
beneficial and interesting to combine the tool with aspects
of MCDA in order to allow for a more detailed stakeholder
evaluation and prioritization of the evidence.
A thorough evaluation of the available tools is highly
desirable, involving a wide range of academic and minis-
try of health partners in a SSA setting in order to ensure
context-specific application of HTA tools. Specific em-
phasis should be made on the need for HTA evaluations
to allow for differences in the evaluations of pharmaceu-
ticals and medical devices. The majority of HTAs cur-
rently focus on the assessment of pharmaceuticals and
tend to neglect medical devices. Due to the varying focus
of the HTA tools that are centred on the evaluation of
medical devices in our review, it is not possible to draw
clear conclusions on the appropriate emphasis of the de-
velopment of medical device HTA tools.
Study limitations
The methodology for the evaluation on each quality cri-
teria point highlighted in Table 3 “Extraction Form for
Principles for HTA Activities in SSA” is based on broad
expert opinion elicitation in our research consortium,
which represents different areas and institutions such as
academia, WHO, HTA expertise, and political decision
makers. Ultimately, the evaluation on the basis of expert
opinion is a subjective assessment of the research con-
sortium which may be subject to potential bias and as
such has to be highlighted as a study limitation.Conclusions
Our review has emphasised that there is a lack of HTA
tools that can be used for systematically assessing technol-
ogy in the SSA context. A clear gap in HTA methodology
focused on “resource-limited” settings, and particularly
the SSA context, calls for more research into further
evaluating and developing relevant HTA methods and ap-
proaches, especially in the context of the WHO resolution
on “Health Intervention and Technology Assessment in
Support of Universal Health Coverage”.
An appropriate HTA tool for “resource-constrained”
settings, and especially SSA, should address all import-
ant criteria of decision making. By combining the two
most promising tools, KNOW ESSENTIALS and MCDA,
appropriate analysis of evidence with a robust and flex-
ible methodology could be applied for the SSA set-
ting. Although there are a range of arguments favouring
the need for HTA in the SSA context, advocacy for the




Keywords included synonyms for the following topic
(“Health Technology Assessment” OR “HTA” OR “health
technology evaluation” OR “priority setting”) AND
(“Developing countr*” OR “low income countr*” OR “re-
source-limited” OR “resource-constrain” OR “Africa”). In
addition, the names of all sub-Saharan African countries
were separately listed as search terms:
“Developing countr*” OR “low income countr*” OR
“resource-limited” OR “resource-constrain*” OR Africa*
OR Angola OR Benin OR Botswana OR “Burkina Faso”
OR Burundi OR Cameroon OR “Cape Verde” OR “Central
African Republic” OR Chad OR Comoros OR Congo
OR “Democratic Republic of Congo” OR Djibouti OR
“Equatorial Guinea” OR Eritrea OR Ethiopia OR Gabon
OR Gambia OR Ghana OR Guinea OR “Guinea Bissau”
OR “Ivory Coast” OR “Cote d’Ivoire” OR Jamahiriya OR
Jamahiryia OR Kenya OR Lesotho OR Liberia OR
Madagascar OR Malawi OR Mali OR Mauritania
OR Mauritius OR Mayote OR Mozambique OR Mocambique
OR Namibia OR Niger OR Nigeria OR Principe OR
Reunion OR Rwanda OR “Sao Tome” OR Senegal OR
Seychelles OR “Sierra Leone” OR Somalia OR “South
Africa” OR “St Helena” OR Sudan OR Swaziland OR
Tanzania OR Togo OR Tunisia OR Uganda OR “Western
Sahara” OR Zambia OR Zimbabwe AND “Health
Technology Assessment” OR HTA OR “health technol-
ogy evaluation” OR “priority setting”.Abbreviations
HTA: Health technology assessment; MCDA: Multi-criteria decision analysis;
SSA: Sub-Saharan Africa.
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